OKYO
OKYO
NASDAQ · Biotechnology

Okyo Pharma Ltd

$1.50
-0.02 (-1.32%)
As of Jun 30, 10:37 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,826.0% upside
Low Target $16.92
Average Target $28.89
High Target $30.86
Current Price $1.50
Current
$1.50
Target
$28.89
$16.92 $28.89 avg $30.86
Scenario Analysis
Bear Case
$16.92
1,028.0%
Low target
Base Case
$28.89
+1,826.0%
Avg target
Bull Case
$30.86
+1,957.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.35
-55.2% from high
52-Week Low
$1.42
+5.6% from low
Target vs 52W High
$28.89
+762.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%